6 results
Parenteral Antimicrobial Treatment of Common Microorganisms Causing Native Vertebral Osteomyelitis - IDSA 
Staphylococci, oxacillin susceptible
Staphylococci, oxacillin
Antimicrobial Treatment ... Native Vertebral Osteomyelitis ... - IDSA Staphylococci ... #pharmacology # ... idsa
IDSA 2017 CDiff Guidelines - Table 7. Potential Treatment Agents for Treatment of the Primary Clostridium difficile
IDSA 2017 CDiff ... Potential Treatment ... Agents for Treatment ... infection Episode #Pharmacology ... #Management #CDiff
Selected Oral Antibacterial Agents With Excellent Oral Bioavailability Commonly Used to Treat Patients With Native Vertebral
Native Vertebral Osteomyelitis ... #Antibiotics #Osteomyelitis ... #management #treatment ... #pharmacology # ... idsa
Potential Treatment Agents for Treatment of the Primary Clostridium difficile infection Episode
Proven efficacy:
 • Vancomycin -
Potential Treatment ... Agents for Treatment ... × 10 days #CDiff ... #management #pharmacology ... #idsa #table
IDSA - Approach to Treating a Patient With Diabetic Foot Osteomyelitis
When to consider a trial of
IDSA - Approach ... Diabetic Foot Osteomyelitis ... of nonsurgical treatment ... 48–72 h if on treatment ... comorbidities confer
IDSA Recommendations for Treating Bartonella Infections in HIV-AIDS
Preferred Therapy
For Bacillary Angiomatosis, Peliosis Hepatis, Bacteremia, and Osteomyelitis:
IDSA Recommendations ... Bacteremia, and Osteomyelitis ... Bartonellosis #IDSA ... #Prevention #Treatment ... infections #HIVAIDS #pharmacology